Normal Healthy Volunteers Clinical Trial
Official title:
Impact of Endogenous Estrogen on Somatostatin Inhibition and Growth Hormone Rebound in Older Women
Endogenous estrogens maintain growth hormone (GH) secretion in postmenopausal women by potentiating endogenous GH-releasing hormone (GHRH) drive and restraining somatostatin inhibition of GH release.
Systemic concentrations of testosterone (Te), estradiol (E2), GH, IGF-I and IGFBP-3 decline in healthy aging individuals (1-3). Sex-steroid deprivation accentuates GH and IGF-I depletion, since Te and E2 stimulate GH and IGF-I production in older adults, hypogonadal patients of all ages, and patients undergoing gender reassignment (1,2,4). Tamoxifen blocks the effect of Te, suggesting involvement of E2 in GH's stimulation in men (5). E2 also stimulates GH secretion in women, putatively via the nuclear estrogen receptor (ER-alpha) (1,2,6,7). Because Te, E2 and GH fall with menopause, and Te is converted to E2 by aromatization in the body (8-10), we postulate that diminished Te concentrations, Te→E2 concentrations and low E2 mediate low GH output in older women. What remains unknown is whether the low E2 levels in postmenopausal women retain GH-stimulating effects. To test this notion would require blocking: (i) aromatase-enzyme activity, which mediates E2 synthesis from Te, and/or (ii) estrogen receptor-alpha, which transduces most of E2's stimulation of the GH axis. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Basic Science
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05019950 -
Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
| Completed |
NCT01366339 -
Tolerance and Pharmacokinetics Study of MNTX Tablets
|
Phase 1 | |
| Completed |
NCT01862835 -
Impact of Estradiol Addback
|
Phase 1 | |
| Completed |
NCT01629446 -
Lofexidine Mass Balance in Volunteers
|
Phase 1 | |
| Completed |
NCT03860571 -
Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers
|
Phase 1 | |
| Recruiting |
NCT03234504 -
Development and Validation of a Novel Stereoacuity Test Using Head-mounted Display
|
||
| Completed |
NCT04188730 -
A Study Evaluating the Relative Bioavailability of Lofexidine Granules for Reconstitution Compared to LUCEMYRA (Lofexidine) Tablets and the Effect of Food on the Bioavailability of the Lofexidine Granules for Reconstitution
|
Phase 1 | |
| Completed |
NCT02271282 -
Estradiol-Receptor Blockade in Older Men and Women
|
Phase 1 | |
| Withdrawn |
NCT03291158 -
Safety and PK Trial Evaluating the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations of Minocin IV
|
Phase 1 | |
| Completed |
NCT02802631 -
Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Minocin (Minocycline) for Injection in Healthy Adults
|
Phase 1 |